NCT01674595View on ClinicalTrials.gov

An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Allergic Rhinitis Due to Olea Europaea Pollen
Interventions
BIOLOGICAL

AVANZ olea

Immunotherapy Olea europaea

Trial Locations (1)

14004

Hospital Universitario Reina Sofía, Córdoba

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01674595 - An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy | Biotech Hunter | Biotech Hunter